Jaypirca Tablet, Coated
Product Images NDC 0002-7026

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Jaypirca (NDC 0002-7026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Jaypirca 100 mg Tablets, 30 Count Bottle (Jaypirca 100mg Bottle 074 00)

JAYPIRCA 100 mg coated tablets label for oral use, containing pirtobrutinib. The label indicates a package size of 60 tablets and includes the NDC number 0002-7026-60. It is manufactured and marketed by Eli Lilly and Company, Indianapolis, IN, USA. Storage and usage instructions are also visible.*

FDA Label Image

Package Label – Jaypirca 50 mg Tablets, 30 Count Bottle (Jaypirca 50mg Bottle 076 00)

Label for Jaypirca (pirtobrutinib) tablets, 50 mg strength. The label shows the NDC number 0002-6902-30 and indicates a count of 30 tablets. It includes the Eli Lilly and Company logo and states the product is Rx only with oral route tablets. Storage and handling instructions are also visible.*

FDA Label Image

Chemical Structure (Jaypirca Uspi Chem Str V1)

Chemical structure diagram of pirtobrutinib, showing molecular features including trifluoromethyl, amine, amide, methoxy, and fluorophenyl groups in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.